Whole blood gene expression
Examination of gene expression in the whole blood of 18 OA outpatients (set 2)
revealed that mTOR was significantly downregulated in 8 patients compared to healthy controls, while 10 subjects exhibited mTOR gene upregulation (Supplementary, Fig. 6A ).
Therefore, all the examined OA outpatients were divided into 2 subsets: a "Low mTOR" expression subset (8 patients) and a "High mTOR" expression subset (10 patients). The data regarding relative mTOR gene expression is presented in Supplementary, Table 3 . , Fig. 6 ).
Protein levels of phospho-p70-S6K in isolated PBMCs
We analyzed the protein levels of phospho-p70-S6K serine/threonine kinase in the PBMC fraction of whole blood from 18 OA outpatients (set 2) and 13 end-stage OA subjects (set 2). These studies showed that the "Low mTOR" expression subset OA outpatients possessed significantly lower phospho-p70-S6K protein concentrations in PBMCs compared to the "High mTOR" expression subset OA outpatients and to the endstage OA subjects (Supplementary, Fig. 6F ). When the amount of the examined proteins was evaluated and compared to amounts in healthy subjects, we observed that the "Low mTOR" subset OA outpatients possessed significantly lower phospho-p70-S6K protein. In contrast, protein concentrations of phospho-p70-S6K in the"High mTOR" subset OA outpatients and in the end-stage OA subjects significantly exceeded the concentrations in healthy individuals (Supplementary, Fig. 6F ).
Examination of gene expression in the articular cartilage of the end-stage OA patients
Articular cartilage degradation in the end-stage OA patients at arthroplasty was associated with significantly higher levels of matrix metalloproteinases MMP-13, and MMP-9, as well as type X collagen (COL10A1) gene expression in the cartilage of another sample (set 2) of the end-stage OA patients compared to another sample of healthy subjects (set 2) (Supplementary, Fig. 7 ). This was accompanied by significant upregulation of mTOR expression and downregulation of ULK1 in comparison to healthy controls (Supplementary, Fig. 7) . At the same time, no significant changes in caspase 3 and p21 gene expression in these OA patients versus healthy subjects were observed.
Supplementary, FIGURE LEGENDS
Figure 5. A relationship between mTOR gene expression measured in the blood or articular cartilage from end-stage OA patients (n=11, set 2) without outliers (n=2, set 2). 
